Holopainen Juha M, Vuori Elisa, Moilanen Jukka A O, Zalentein Waldir Neira, Tervo Timo M T
Department of Ophthalmology, University of Helsinki, Helsinki, Finland.
J Cataract Refract Surg. 2007 Oct;33(10):1744-9. doi: 10.1016/j.jcrs.2007.06.023.
To evaluate the long-term effects of excimer laser treatment for ametropia after surgical treatment of rhegmatogenous retinal detachment (RRD) with scleral buckles.
Helsinki University Eye Hospital, Helsinki, Finland.
Ten patients (10 eyes) who had 1 or more surgeries for RRD followed by refractive surgery for myopia were retrospectively enrolled in this study and were examined after excimer laser refractive surgery. Photorefractive keratectomy (PRK) or laser in situ keratomileusis (LASIK) was performed using a Star S2 excimer laser system (Visx). The best spectacle-corrected visual acuity (BSCVA), refraction, degree of anisometropia, and topographical changes were evaluated before and after the surgeries.
All patients were free of asthenopic symptoms after refractive surgery. At the end of the follow-up, a mean of 67 months +/- 14 (SD) after refractive surgery, 6 patients were within +/-1.0 diopter of the intended correction. Compared with previously reported cohorts of myopic patients, the achieved refraction in patients who previously had a scleral buckling procedure was worse. The postoperative refraction was stable, and corneal topography did not show induced scar formation, keratectasia, or irregular astigmatism. After refractive surgery, the BSCVA improved 1 Snellen line in 3 patients and 2 lines in 1 patient. One patient lost 1 Snellen line and another patient lost 2 lines. Four patients showed no changes. New retinal complications were not observed.
In the long-term, PRK and LASIK were safe methods for the treatment of myopia in RRD patients after scleral buckling. The predictability of myopic LASIK/PRK may be worse than generally reported in myopic cohorts.
评估准分子激光治疗巩膜扣带术治疗孔源性视网膜脱离(RRD)后屈光不正的长期效果。
芬兰赫尔辛基大学眼科医院。
本研究回顾性纳入10例(10只眼)因RRD接受1次或多次手术,随后因近视接受屈光手术的患者,并在准分子激光屈光手术后进行检查。使用Star S2准分子激光系统(威视)进行准分子原位角膜磨镶术(PRK)或准分子激光原位角膜磨镶术(LASIK)。评估手术前后的最佳矫正视力(BSCVA)、屈光、屈光参差程度和地形图变化。
所有患者屈光手术后均无眼疲劳症状。随访结束时,屈光手术后平均67个月±14(标准差),6例患者的屈光在预期矫正的±1.0屈光度范围内。与先前报道的近视患者队列相比,先前接受巩膜扣带手术的患者所达到的屈光效果较差。术后屈光稳定,角膜地形图未显示诱导性瘢痕形成、角膜扩张或不规则散光。屈光手术后,3例患者的BSCVA提高了1行,1例患者提高了2行。1例患者下降了1行,另1例患者下降了2行。4例患者无变化。未观察到新的视网膜并发症。
长期来看,PRK和LASIK是巩膜扣带术后RRD患者近视治疗的安全方法。近视LASIK/PRK的可预测性可能比一般近视患者队列报道的要差。